Abeona Therapeutics Inc. ABEO

Updated: 11 Aug 2026

NASDAQ | Biotech | Cell and gene therapy

No signal published yet

We already track Abeona Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Abeona Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Cell and gene therapy
We're already tracking Abeona Therapeutics Inc. — here are the latest events we've registered

Recent News

  • On August 4, 2026, Abeona announced that the Centers for Medicare & Medicaid Services granted New Technology Add-On Payment status for Zevaskyn for Fiscal Year 2027. The designation enables supplemental Medicare reimbursement for qualifying inpatient hospital treatments.

What Firelda Watch includes for Abeona Therapeutics Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Abeona Therapeutics Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Want to follow Abeona Therapeutics Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Abeona Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Abeona Therapeutics Inc. ABEO
Abeona Therapeutics — follow and we'll monitor it
Follow Abeona Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.